Showing results (261-270 of 292) with videos related to

Sort By:
Pageof 30
Cancer Research and Treatment|July 21, 2014
A Phase I Study of Oral Paclitaxel with a Novel P-Glycoprotein Inhibitor, HM30181A, in Patients with Advanced Solid CancerHyun Jung Lee, Dae-Seog Heo, Joo-Youn Cho, et al.
British Journal of Clinical Pharmacology|December 17, 2009
Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteersKyoung Soo Lim, Joo-Youn Cho, Bo-Hyung Kim, et al.
Clinical Pharmacology and Therapeutics|August 4, 2004
Effect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic statesKyung-Sang Yu, Joo-Youn Cho, In-Jin Jang, et al.
Epilepsy & Behavior : E&B|December 17, 2020
Effects of perampanel on cognition and quantitative electroencephalography in patients with epilepsySeon-Jae Ahn, Tae-Joon Kim, Kwang Su Cha, et al.
Korean Journal of Pediatrics|December 27, 2016
Targeted busulfan and fludarabine-based conditioning for bone marrow transplantation in chronic granulomatous diseaseHee Young Ju, Hyoung Jin Kang, Che Ry Hong, et al.
Pharmacogenetics and Genomics|December 17, 2016
Characterization of ADME gene variation in 21 populations by exome sequencingDaniel H Hovelson, Zhengyu Xue, Matthew Zawistowski, et al.
Pharmacogenetics and Genomics|February 9, 2011
Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in KoreansHye-Ryun Kang, Young Koo Jee, Yon-Soo Kim, et al.
Diabetes, Obesity & Metabolism|February 28, 2023
Effect of haemodialysis on the pharmacokinetics and pharmacodynamics of evogliptinByungwook Kim, Dha Woon Im, Heejae Won, et al.
Epilepsia|September 27, 2016
HLA-B*40:02 and DRB1*04:03 are risk factors for oxcarbazepine-induced maculopapular eruptionJangsup Moon, Tae-Joon Kim, Jung-Ah Lim, et al.
Cancer Science|November 21, 2014
ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapyHee-Jun Kim, Seock-Ah Im, Bhumsuk Keam, et al.
Pageof 30